Trevia™

  • All Products
  • By Generic
  • By Therapeutic Segment

Trevia™

Therapeutic Segment: Anti-Diabetic

Generic Name: Sitagliptin phosphate monohydrate

Indication:

Indicated for:
• Lowering blood sugar levels in adult patients with type 2 diabetes mellitus. Type 2 diabetes is also called non-insulin-dependent diabetes mellitus, or NIDDM
• Improving the levels of insulin after a meal and decreases the amount of sugar made by the body.

Available as:

Tablet
  • 50MG
  • 100MG